Additionally, in cancers with aberrant expression of the transcribed pseudogene RPSAP52, HMGA2 enhances the HMGA2-IMP2-RAS axis, promoting IMP2 binding to its mRNA targets and driving translation [43,44,45,46,47]. Here, IGF2BP2 is linked to cancer.